| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |